Shares of Vir Biotechnology (VIR) surged Thursday after the company inked a manufacturing deal with Biogen (BIIB) for a coronavirus treatment.
XIn midday trading on the stock market today, Vir stock popped 9.6%, near 37. Biogen stock, on the other hand, topp…
Read More
